Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
56 hedge funds and large institutions have $1.15B invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 4 closing their positions.
4% more capital invested
Capital invested by funds: $1.11B → $1.15B (+$40.5M)
2% less funds holding
Funds holding: 57 → 56 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 24
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$27.2M |
| 2 |
Two Sigma Investments
New York
|
+$23.9M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$14.5M |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$12.3M |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$59.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.2M |
| 3 |
P8IP
Pier 88 Investment Partners
San Francisco,
California
|
-$10.2M |
| 4 |
JP Morgan Chase
New York
|
-$8.04M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$7.54M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $103K | -$2.03M | -17,674 | -95% |
|
52
Lazard Asset Management
New York
| $78K | – | – | – |
|
53
UBS Group
Zurich,
Switzerland
| $45.4K | -$4.83K | -42 | -10% |
|
54
US Bancorp
Minneapolis,
Minnesota
| $36.3K | – | – | – |
|
55
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $24K | – | – | – |
|
56
Osaic Holdings
Scottsdale,
Arizona
| $13.4K | -$28.8K | -250 | -69% |
|
|
PTC
57
Private Trust Company
Cleveland,
Ohio
| $9.32K | +$6.44K | +56 | +267% |
|
|
PA
58
Parallel Advisors
San Francisco,
California
| $605 | – | – | – |
|
59
Russell Investments Group
London,
United Kingdom
| – | -$371K | -323,100 | Closed |
|
60
Jane Street
New York
| – | -$1.8M | -15,717 | Closed |
|
|
SI
61
Stephens Inc
Little Rock,
Arkansas
| – | -$222K | -1,935 | Closed |
|
|
HDIM
62
Hanson & Doremus Investment Management
Burlington,
Vermont
| – | -$15K | -134 | Closed |
|
BSX.PRA Hedge Fund Activity: Q1 2023 in Review
56 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q1 2023, worth a combined $1.15B — up 3.6% from $1.11B a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BSX.PRA and 3 opened new positions — a net loss of 1 holder — while 24 trimmed existing stakes and 12 added.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $27.2M. The largest seller was VOYA Investment Management, cutting an estimated $59.8M.
- 56 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q1 2023, down from 57 in Q4 2022.
- Funds reported $1.15B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q1 2023, up 3.6% quarter-over-quarter.
- 3 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q1 2023 and 4 closed out, a net change of -1 holder.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q1 2023 was Bank of Montreal, an estimated $27.2M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q1 2023 was VOYA Investment Management, an estimated $59.8M sold.
Based on aggregated 13F filings for Q1 2023.